Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
Author(s) -
Atsuko Hata,
Hideomi Asanuma,
Mary Rinki,
Margaret Sharp,
Ruby M. Wong,
Karl G. Blume,
Ann M. Arvin
Publication year - 2002
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa013441
Subject(s) - medicine , varicella zoster virus , transplantation , varicella vaccine , hematopoietic cell , hematopoietic stem cell transplantation , virus , lymphoma , immunology , surgery , gastroenterology , haematopoiesis , immunization , immune system , stem cell , biology , genetics
The reactivation of varicella-zoster virus from latency causes zoster and is common among recipients of hematopoietic-cell transplants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom